Login / Signup

Fatty acid-binding protein-3 and renal function decline in patients with chronic coronary syndrome.

Jiunn-Tyng YehChin-Chou HuangHsin-Bang LeuWei-Hsian YinWei-Kung TsengYen-Wen WuTsung-Hsien LinHung-I YehKuan-Cheng ChangJi-Hung WangChau-Chung WuJaw-Wen Chen
Published in: Clinical cardiology (2024)
Serum FABP-3 may serve as a novel biomarker to predict eGFR decline in patients with chronic coronary syndrome.
Keyphrases
  • binding protein
  • coronary artery disease
  • coronary artery
  • fatty acid
  • small cell lung cancer
  • case report
  • epidermal growth factor receptor
  • tyrosine kinase
  • heart failure